Two‐stage phase II survival trial design-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Two‐stage phase II survival trial design

Published:2019-11-21 Issue:3 Volume:19 Page:214-229
ISSN:1539-1604
Container-title:Pharmaceutical Statistics
language:en
Short-container-title:Pharmaceutical Statistics

Author:

Wu Jianrong¹²^ORCID,Chen Li¹²,Wei Jing³,Weiss Heidi¹²,Chauhan Aman⁴

Affiliation:

1. Biostatistics and Bioinformatics Shared Resource FacilityUniversity of Kentucky Lexington Kentucky USA

2. Markey Cancer CenterUniversity of Kentucky Lexington Kentucky USA

3. Department of StatisticsUniversity of Kentucky Lexington Kentucky USA

4. Department of Internal MedicineDivision of Medical Oncology, University of Kentucky Lexington Kentucky USA

Funder

National Cancer Center

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology,Statistics and Probability

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/pst.1983

Reference17 articles.

1. Optimal two-stage designs for phase II clinical trials

2. Design of Phase II cancer trials evaluating survival probabilities

3. Optimal Two-Stage Phase II Designs with Long-Term Endpoints

4. Optimal Designs With Interim Analyses for Randomized Studies With Long-Term Time-Specific Endpoints

5. Group Sequential Designs for Monitoring Survival Probabilities

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Isatuximab, Carfilzomib, Lenalidomide, and Dexamethasone for the Treatment of High-Risk Newly Diagnosed Multiple Myeloma;Journal of Clinical Oncology;2024-01-01

2. OneArm2stage: Phase II Single-Arm Two-Stage Designs with Time-to-Event Outcomes;CRAN: Contributed Packages;2022-09-07

3. Two‐stage screened selection designs for randomized phase II trials with time‐to‐event endpoints;Biometrical Journal;2022-06-05

4. Bayesian single‐arm phase II trial designs with time‐to‐event endpoints;Pharmaceutical Statistics;2021-06-04

5. Optimal two-stage design of single arm Phase II clinical trials based on median event time test;PLOS ONE;2021-02-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3